Skip to main content
CATIE: Canada's Source for HIV and hepatitis C information
Website search form input
français
    français
  • Essentials
    • HIV Basics
    • Hepatitis C Basics
    • STI basics
    • Statistics
      • HIV statistics
      • Hepatitis C statistics
      • STI statistics
    • Government and community strategies
      • National
      • Provincial/territorial
      • International
    • Social determinants of health
    Menu Callout Title

    Essentials

    Menu Callout Body

    Background information on HIV, hepatitis C and STIs in Canada, including basic information, statistics (epidemiology), provincial and national strategies to address HIV, hepatitis C and STIs, and social determinants of health.

  • Prevention
    • How transmission occurs
      • HIV transmission
      • Hepatitis C transmission
    • Prevention methods
      • Condoms and other physical barriers
      • HIV pre-exposure prophylaxis (PrEP)
      • HIV treatment and an undetectable viral load
      • HIV post-exposure prophylaxis (PEP)
      • Safer injecting and smoking supplies
      • Supervised consumption services/Overdose prevention sites
      • Opioid agonist therapy
      • Safer tattooing and piercing
      • Universal precautions
    • Safer sex
      • General safer sex
      • Sexually transmitted infections
    • Harm reduction
      • General harm reduction
      • Information on substances
      • Safer injecting and smoking supplies
      • Supervised consumption services/Overdose prevention sites
      • Opioid agonist therapy
    • Pregnancy and infant feeding
    • Microbicides and vaccines
    Menu Callout Title

    Prevention

    Menu Callout Body

    Information on HIV and hepatitis C transmission and prevention, including STIs and safer sex, harm reduction, pregnancy and infant feeding, and microbicides and vaccines.

  • Testing & Diagnosis
    • HIV testing and diagnosis
    • Hepatitis C testing and diagnosis
    • STI testing and diagnosis
    Menu Callout Title

    Testing and diagnosis

    Menu Callout Body

    Information on diagnostic tests for HIV, hepatitis C and STIs; the delivery of testing and counselling; and resources for people who are newly diagnosed.

  • Treatment & Care
    • HIV treatment, care and support
      • HIV medications
      • Treatment and medical care
      • Paying for treatment
      • Healthy living
      • Pregnancy and infant feeding
      • Disclosure
      • Clinical trials
      • Cure research
    • Hepatitis C treatment, care and support
      • Hepatitis C medications
      • Treatment and medical care
      • Paying for treatment
      • Re-infection
      • Long-term liver health
    • STI treatment
    Menu Callout Title

    Treatment and care

    Menu Callout Body

    Information on treatment, care and support for HIV, hepatitis C and STIs, including medications, healthy living, pregnancy and infant feeding, hepatitis C re-infection, and long-term health issues.

  • Education, Publications & Websites
    • Education
      • Open courses
      • Partnered courses
      • Self-directed learning
      • Webinars
      • Continuing Education Centre
    • Order a publication
      • CATIE Ordering Centre
    • Service provider publications
      • CATIE News
      • CATIE statements
      • Fact sheets
      • Harm Reduction Fundamentals
      • Hepatitis C: An In-Depth Guide
      • Prevention in Focus
      • Programming Connection
      • The HIV Handbook
      • TreatmentUpdate
    • Client publications
      • Managing Your Health
      • The Positive Side
      • Publications by topic
    • Websites
      • CATIE Ordering Centre
      • Where To?
      • Sage
      • CATIE Blog
      • Hepatitis C Information for Immigrants and Newcomers
    Menu Callout Title

    Education, publication and websites

    Menu Callout Body

    CATIE’s online educational courses, webinars, online and print publications, and other websites.

  • About CATIE
    • What we do
      • About CATIE
      • Vision, mission, values
      • Our history
      • Annual reports
      • CATIE evaluation reports
    • Governance
      • Membership
      • Board of Directors
      • Strategic plan
    • Supporting our work
      • Career opportunities
      • Funders and partners
      • Donate to CATIE
    • Contact Us
    Menu Callout Title

    About CATIE

You are here

  1. Home

TreatmentUpdate 229

Anti-HIV Agents
View Contents
Updated December 2018
Image
catie-book-icon
File
Download pdf

Contents

TreatmentUpdate 229
The emergence of dual drug therapy
Dolutegravir + 3TC for the initial treatment of HIV
Dual maintenance therapy with dolutegravir + rilpivirine
Italian study explores dual drug regimens as maintenance treatment
Dual drug therapy—impact on the HIV reservoir
Combinations of super antibodies may keep HIV at bay
Monkey study uncovers the potential for vesatolimod and antibodies in cure research
File
Download pdf

Book traversal links for TreatmentUpdate 229

  • Subscriptions
  • Become a Member
  • Funders
Donate
  • Facebook
  • Twitter
  • Youtube
  • Statement on Truth and Reconciliation
  • Privacy
  • Permission to Reproduce
  • Disclaimer

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.